Digital Therapeutic Trial for Overactive Bladder Shows Promise: RiSolve App Completes Post-Market Evaluation in Irish Women

References

1. 1.University of Galway. (2024). A Prospective Evaluation of a Prescription Digital Therapeutic for Treatment of Overactive Bladder in Women: The RiSolve Trial. ClinicalTrials.gov. NCT07206446. https://clinicaltrials.gov/study/NCT07206446
2. 2.Gormley, E. A., Lightner, D. J., Burgio, K. L., Chai, T. C., Clemens, J. Q., Culkin, D. J., Das, A. K., Foster, H. E., Scarpero, H. M., Tessier, C. D., & Vasavada, S. P. (2012). Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. Journal of Urology, 188(6 Suppl), 2455-2463. https://doi.org/10.1016/j.juro.2012.09.079
3. 3.Milsom, I., Kaplan, S. A., Coyne, K. S., Sexton, C. C., & Kopp, Z. S. (2012). Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology, 80(1), 90-96. https://doi.org/10.1016/j.urology.2012.07.088
4. 4.Lightner, D. J., Gomelsky, A., Souter, L., & Vasavada, S. P. (2019). Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. Journal of Urology, 202(3), 558-563. https://doi.org/10.1097/JU.0000000000000309
5. 5.Irwin, D. E., Milsom, I., Hunskaar, S., Reilly, K., Kopp, Z., Herschorn, S., Coyne, K., Kelleher, C., Hampel, C., Artibani, W., & Abrams, P. (2006). Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. European Urology, 50(6), 1306-1315. https://doi.org/10.1016/j.eururo.2006.09.019
6. 6.Peyronnet, B., Mironska, E., Chapple, C., Cardozo, L., Oelke, M., Dmochowski, R., Amarenco, G., Gamé, X., Kirby, R., Van Der Aa, F., Cornu, J. N., & European Association of Urology Guidelines Panel on Urinary Incontinence. (2019). A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. European Urology, 75(6), 988-1000. https://doi.org/10.1016/j.eururo.2019.02.038